KORU Medical Systems is evolving into a digitally enabled drug delivery platform, benefiting from growth in at-home subcutaneous infusion therapies. The company reported an 18.2% increase in Q2 revenue to $12.05 million, with improved net income and gross margins rising to 65.1%, driven by strong domestic performance and expanding international sales. However, international growth is slower than expected, leading KORU to narrow its full-year revenue guidance to $47.5 million–$48.5 million while raising its gross margin outlook to 62%–64%. Management aims for long-term targets of $100 million in revenue, gross margins above 65%, and EBITDA margins of at least 20%, with positive adjusted EBITDA anticipated by fiscal year 2026.
When leaving Austria with significant Bitcoin holdings, the country may impose an exit tax calculated as if the Bitcoin were sold at the moment of departure, based on the market value then. If moving to an EU or EEA country, tax payment can be deferr...
Stanley Druckenmiller invested $64.7 million in Bitdeer, a bitcoin mining and data center operator, and $23.1 million in Hyperliquid Strategies, a decentralized trading platform, during Q2 2026. These moves reflect his growing interest in digital ass...
U.S.-listed spot Bitcoin and Ether ETFs attracted a combined $2.61 billion over five trading sessions, marking their strongest weekly inflows since October 2025. Bitcoin ETFs led with $1.92 billion, making up 73% of the total, while Ether ETFs added ...
On August 21, Uniswap burned approximately 150,000 UNI tokens valued at $590,000, marking a new daily record. This burn is part of Uniswap's fee switch mechanism, which uses trading fees to buy and burn UNI tokens, reducing supply and creating deflat...
Fetch.ai (FET) surged more than 15% in 24 hours, reaching $0.15, supported by strong long positions and positive funding rates in its perpetual market. Spot market demand remains robust, with significant net outflows to private wallets indicating str...
